PrairieView Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

PrairieView Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3K	Buy	+126	New	+$2.76K	﹤0.01%	321
2024 Q3	–	Sell	-126	Closed	-$2K	–	355
2024 Q2	$2K	Hold	126	–	–	﹤0.01%	336
2024 Q1	$4K	Hold	126	–	–	﹤0.01%	312
2023 Q4	$4K	Hold	126	–	–	﹤0.01%	304
2023 Q3	$3K	Hold	126	–	–	﹤0.01%	329
2023 Q2	$4K	Hold	126	–	–	﹤0.01%	371
2023 Q1	$3K	Hold	126	–	–	﹤0.01%	358
2022 Q4	$3K	Hold	126	–	–	﹤0.01%	392
2022 Q3	$4K	Hold	126	–	–	﹤0.01%	360
2022 Q2	$4K	Sell	126 -4	-3%	-$140	﹤0.01%	376
2022 Q1	$6K	Buy	130 +4	+3%	+$191	﹤0.01%	352
2021 Q4	$8K	Buy	+126	New	+$8.71K	﹤0.01%	325

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PrairieView Partners's ARKG Position: Q2 2025 in Review

PrairieView Partners opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2025: 126 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #321 among its holdings. This is a return to the name: PrairieView Partners previously reported a position in ARKG as recently as Q2 2024.

PrairieView Partners first reported a position in ARKG in Q4 2021 and has held it in 12 quarters since. The position peaked at $8K in Q4 2021. 213 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

PrairieView Partners held 126 shares of ARK Genomic Revolution ETF worth $3K as of Q2 2025.
ARK Genomic Revolution ETF was a new PrairieView Partners position in Q2 2025.
ARK Genomic Revolution ETF made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #321 holding.
PrairieView Partners first reported a position in ARK Genomic Revolution ETF in Q4 2021 and has held it in 12 quarters since.
PrairieView Partners's ARK Genomic Revolution ETF position peaked at $8K in Q4 2021.
213 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.